Reducing Hereditary Cancer Act of 2021

Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

DWD Wasserman SchultzSponsor

56 cosponsors · 45 D, 11 R

RDR Davis MMR Miller-Meeks ESD Slotkin BFR Fitzpatrick JHD Hayes SJD Jackson Lee JBD Brownley JLD Larson JVR Van Drew KMD Mfume CCD Crist JND Neguse SBD Bonamici NBD Barragán KCD Castor YCD Clarke TCD Cárdenas DDD Dingell MKD Kaptur DKD Kilmer AKD Kuster DMD Matsui AMD McEachin CRD Ruppersberger RRD Ruiz JSD Schakowsky DSD Soto DTD Trone MVD Veasey TOD O’Halleran LTD Trahan DDD DeGette SJD Jacobs DBR Bacon ALD Lawson JHR Herrera Beutler MAR Amodei ADD Delgado RKD Khanna SCD Cohen JCD Chu BHD Higgins JMD Morelle ACD Carson SCD Carbajal JGD Gottheimer LBR Bucshon BJR Johnson PTD Tonko PAD Aguilar JHD Harder CBD Bush NDR Dunn GPR Pence GMD Moore SLD Lynch

3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.